Glasgow, United Kingdom · Founded 2016 · Privately Held (backing)
Developer of a liquid biopsy-based cancer diagnostics platform designed for the early detection of multiple cancer types. Dxcover is based in Glasgow, United Kingdom and was founded in 2016. Its last reported valuation was $37.8 million in Jan 2025. It has raised $21.8 million.
Last reported valuation
$37.8M
Oct 2026
Priced at
—
Total raised
$21.8M
Last round
—
Team — not yet on record
No current team members for Dxcover are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Dxcover with a free account
·The complete investor list: 24 names
·Watch Dxcover: the Monday email on marks, rounds and moves
